Eiko Lifesciences Ltd - 540204 - Opening Of Trading Window
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015, and the Company''''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, please be informed that the trading window for dealing in the securities of the Company by the Designated Persons shall open on Friday, February 3, 2023. Eiko Lifesciences Ltd - 540204 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, we herewith enclose Newspaper publication of Postal Ballot Notice published today i.e on 02.02.2023. Eiko Lifesciences Ltd - 540204 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Postal Ballot Notice - Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Eiko Lifesciences Ltd - 540204 - CALENDER OF EVENTS FOR POSTAL BALLOT
CALENDER OF EVENTS FOR POSTAL BALLOT Eiko Lifesciences Ltd - 540204 - Board Meeting Outcome for Outcome Of Board Meeting Held On 31St January, 2023
The Board considered and approved the following 1. To Increase Authorized Share Capital of the Company 2. Fund raising and issuance of fully paid equity shares of the company for an amount not exceeding ?25 Crores (Rupees Twenty Five Crores Only) by way of a right issue . 3. To seek requisite members approval for increase in authorised Share Capital of the Company. 4. Appointment of M/s. Shravan Gupta and Associates, Practicing Company Secretary as a Scrutinizer for the purpose of conducting Postal Ballot Eiko Lifesciences Ltd - 540204 - Intimation Under Regulation 30 And 31A Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, ("Listing Regulations") - Receipt Of Approval For Reclassification Of Promoter From ''Promoter Category '' To ''Public Category''.
Intimation under Regulation 30 and 31A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, ("Listing Regulations") - Receipt of approval for reclassification of Promoters from ''Promoter Category'' to ''Public Category''. Eiko Lifesciences Ltd - 540204 - Closure of Trading Window
This is to inform you that as per SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company''s Code of Conduct for Prevention of Insider Trading (the "Code of Conduct") framed in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the trading window for dealing in the securities shall remain closed from Thursday, 26th January, 2023 till the end of 48 hours from the conclusion of the meeting of the Board i.e. till Thursday, February 02, 2023, both days inclusive, for all connected persons/officers/designated employees/ insiders, directors of the Company and immediate relatives of these persons, including but not limited to the persons specified in the Company''s Code of Conduct. The trading window for dealing in securities of the Company shall reopen on Friday, February 03, 2023. Eiko Lifesciences Ltd - 540204 - Update on board meeting
The Board Meeting to be held on 31/01/2023 has been revised to 31/01/2023 Kindly ignore the previous intmitation. To consider the proposal for raising funds by way of issue of one or more instruments including equity shares, convertible or non-convertible securities of any description or warrants or debt securities, through preferential issue, private placements, right issue or any other methods or combination thereof as may be permitted under applicable laws, subject to such regulatory / statutory approvals as may be required, including the approval of the shareholders of the company. Eiko Lifesciences Ltd - 540204 - Board Meeting Intimation for Fund Raising
Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2023 ,inter alia, to consider and approve the proposal for raising funds by way of issue of one or more instruments including equity shares, convertible or non-convertible securities of any description or warrants or debt securities, through preferential issue, private placements, right issue or any other methods or combination thereof as may be permitted under applicable laws, subject to such regulatory / statutory approvals as may be required, including the approval of the shareholders of the company. Eiko Lifesciences Ltd - 540204 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We enclose herewith copy of advertisements giving information of the financial results as specified in Regulation 33 of Listing Regulations. The above mentioned advertisement is published in The Financial Express (English Newspaper) & Mumbai Lakshadweep(Marathi Newspaper) on January 18, 2023.